Cite

HARVARD Citation

    Labussière, M. et al. (2016). Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma. Cancer investigation. pp. 39-44. [Online]. 
  
Back to record